naphazoline
| SMILES | C1CN=C(N1)Cc1cccc2c1cccc2 |
| InChIKey | CNIIGCLFLJGOGP-UHFFFAOYSA-N |
Chemical properties
| Hydrogen bond acceptors | 2 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 2 |
| Molecular weight (Da) | 210.1 |
Drug properties
| Molecular type | Small molecule |
| Endogenous/Surrogate | Surrogate |
| Approved drug | Yes |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.39 | 6.39 | 6.39 | PDSP Ki database |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.39 | 6.39 | 6.39 | PDSP Ki database |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 7.68 | 7.68 | 7.68 | PDSP Ki database |
| α2A | ADA2A | Mouse | Adrenoceptors | A | pKi | 7.77 | 7.86 | 7.94 | PDSP Ki database |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 8.11 | 8.11 | 8.11 | Drug Central |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.19 | 8.19 | 8.19 | Drug Central |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 8.64 | 8.64 | 8.64 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1A | ADA1A | Human | Adrenoceptors | A | pEC50 | 7.2 | 7.2 | 7.2 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pEC50 | 7.26 | 7.26 | 7.26 | ChEMBL |
| TA1 | TAAR1 | Human | Trace amine | A | pEC50 | 6.85 | 6.85 | 6.85 | ChEMBL |
| TA1 | TAAR1 | Human | Trace amine | A | pIC50 | 5.94 | 5.94 | 5.94 | ChEMBL |